Health Care: Drugs

EntreMed Inc (ENMD: NASDAQ)

$1.94 -0.03 | -1.52%
04/23/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.97
52 Week High 2.38
52 Week Low 1.45
Avg. Daily Vol. (Mil) 0.02
Beta (3 year) 2.31
Share Related Items
Mkt Cap (Mil) 53.27
Shares Out (Mil) 27.04
Float (Mil) 19.36
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 26.80
Current Ratio 27.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 3.57
Price/Cash Flow -9.30
Per Share Data
Earnings -0.22
Sales 0.00
Book Value 0.55
Cash Flow -0.21
Business Summary
EntreMed, Inc. is a clinical-stage pharmaceutical company. It develops therapeutic candidates for the treatment of cancer and inflammation.
General Information
9640 Medical Center Drive
Suite 300
Rockville, MD 20850
Industry : Drugs
Sector: Health Care
Employees: 15
CEO: Dr. Ken Keyong Ren
Short Interest
Current Month (Mil) 0.04
Previous Month (Mil) 0.04
Short Interest Ratio (Days) 1.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -37.00
Return on Investments -38.40
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ENMD

Latest ENMD Headlines from TheStreet

More Financial News for ENMD

Press Releases for ENMD

See All Press Releases

Partner Headlines for ENMD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter